SCHEMBL7414910

SCHEMBL7414910

CC1(C)C2CCC1(CS(=O)(=O)NC(CNS(=O)(=O)c1ccc(Cl)cc1)C(=O)NO)C(=O)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 7/20 0.49
CA2 P00918 7/20 0.49
CA5A P35218 7/20 0.49
CA5B Q9Y2D0 7/20 0.49
ALDH1A1 P00352 6/20 0.48
LMNA P02545 2/20 0.48
CYP2C19 P33261 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
HSD17B10 Q99714 1/20 0.45
BCL2 P10415 2/20 0.44
BAK1 Q16611 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7420995 0.93 CA1 (0.51) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7413879 0.90 ALDH1A1 (0.48) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7416192 0.90 ALDH1A1 (0.58) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7414565 0.88 ALDH1A1 (0.44) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7413675 0.86 ALDH1A1 (0.54) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7416012 0.85 CA1 (0.52) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7414255 0.83 ALDH1A1 (0.44) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7411847 0.83 ALDH1A1 (0.58) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7413360 0.83 CA1 (0.49) CA1CA2CA5ACA5BALDH1A1
SCHEMBL7419003 0.83 ALDH1A1 (0.47) CA1CA2CA5ACA5BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed